# Sit Less, Interact and Move More (SLIMM) 2 Study

> **NCT05173714** · PHASE2 · RECRUITING · sponsor: **Srinvasan Beddhu** · enrollment: 156 (estimated)

## Conditions studied

- Chronic Kidney Diseases
- Obesity

## Interventions

- **BEHAVIORAL:** SLIMM
- **BEHAVIORAL:** Standard Resistance Training
- **BEHAVIORAL:** Guided Resistance Training
- **DRUG:** Placebo
- **DRUG:** Semaglutide

## Key facts

- **NCT ID:** NCT05173714
- **Lead sponsor:** Srinvasan Beddhu
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2025-06-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05173714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05173714, "Sit Less, Interact and Move More (SLIMM) 2 Study". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05173714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*